HEMPGenTech

High Efficiency Multi-crop Platform (H.E.M.P.™) Genetic Technologies

Australian Plant Breeding & Commercial Genetics

Industrial Hemp Genetics, Agronomy & Commercialisation

HEMPGenTech develops and commercialises industrial hemp genetics and production systems for growers, seed partners and commercial programs in Australia and international markets.

Who we are

Building Stronger Foundations for Emerging Crop Industries

HEMPGenTech was established to bring serious genetics, agronomy and seed-system discipline into emerging crop industries.

The company operates where science meets commercial reality—connecting variety development, crop management, seed quality, compliance awareness, licensing and market development.

Its current focus is industrial hemp and sesame, with capability that can support other emerging crops requiring stronger genetic, technical and commercial foundations.

Genetics & breeding

Australian Industrial Hemp Genetics

HEMPGenTech develops genetics around the interaction between genotype, environment, management and end use. Commercial readiness is treated separately from breeding status, Plant Breeder’s Rights protection, seed multiplication, regulatory availability and market deployment.

7commercial-ready or advanced varieties presented by HGT
52026 PBR applications submitted to IP Australia
12additional breeding lines maintained in the development pipeline
1integrated genetics, agronomy and seed-system platform

Stage 1

Current Commercial Varieties

Commercial enquiries open

HGT1

HGT1 is a dioecious industrial hemp variety suited to selected grain, fibre and dual-purpose production systems, depending on location, sowing window, end use, seed availability and management.

Enquire about HGT1 planting seed

HGT2h

HGT2h is a monoecious, grain-focused industrial hemp variety developed for selected commercial production systems where local conditions, compliance, seed availability and management are suitable.

Enquire about HGT2h planting seed

Stage 2

Advanced Commercial-Ready Variety Cohort

PBR applications submitted

Five additional HGT varieties have progressed to an advanced commercial-ready stage, with Plant Breeder’s Rights applications submitted to IP Australia in 2026. Commercial release and supply remain subject to final HGT approval, seed multiplication, regulatory requirements and market readiness.

HOMA2hs

HARMONEY32

HASTI20

HARIR57

HALEH98

Status distinction: these varieties are presented as advanced commercial-ready genetics. PBR application, PBR grant, regulatory registration, seed multiplication and commercial availability remain separate steps.

Stage 3

12-Line Development Pipeline

Under internal evaluation

HEMPGenTech maintains a further 12 breeding lines in its development pipeline. Seven identifiers are currently presented publicly below; five additional numbered internal lines remain under evaluation and will be named publicly only when their identifiers and status are confirmed for release.

  • HGT10598
  • HGT10533
  • HGT040
  • HGT020
  • HGT057
  • HGT029
  • HGT103
  • + 5 additional internal numbered lines

Agronomy

Six Linked Decisions, Not One Generic Recipe

HGT’s current agronomy review work reinforces a practical point: industrial hemp management must be designed around genotype × environment × management and the intended end use. Recommendations are therefore developed as a connected system rather than a universal sowing or input prescription.

End Use

Define grain, fibre, dual-purpose, seed multiplication, research or another authorised objective before selecting the production pathway.

Variety & Flowering

Match genetic background and flowering response with latitude, season length, photoperiod and the required harvest window.

Sowing & Establishment

Consider soil condition, seed quality, sowing window, depth, equipment, plant density and establishment risk together.

Water & Nutrition

Build irrigation and nutrient decisions around soil evidence, crop stage, end-use target and seasonal conditions.

Crop Protection

Use proactive monitoring and integrated approaches to weed, pest and disease pressure within the applicable local rules.

Harvest & Quality

Align crop maturity, machinery, harvest timing, handling and post-harvest requirements with the buyer and product pathway.

Technical information is general. A commercial program requires local assessment of variety, region, season, management, equipment, end use and regulation.

Seed systems

Five Control Points from Genetics to Planting Seed

Genetic value is only useful when it can be reproduced and delivered through a reliable seed pathway. HEMPGenTech works with HGT Seed Services to connect variety identity, multiplication planning, quality assurance coordination, traceability and delivery readiness.

Identity

Start with the correct variety, authorised source and clear intended use.

Multiplication

Plan generation, isolation, field controls, timing and expected supply needs before scale-up.

Quality Assurance

Coordinate appropriate germination, purity, health and other testing through relevant services and schemes.

Traceability

Maintain lot identity, chain-of-custody information, retained records and supporting documentation.

Delivery Readiness

Resolve availability, packaging, logistics, permits and planting timing before committing the production program.

HGT supports certification pathways and quality-assurance coordination but does not represent itself as the government, scheme authority or laboratory that issues official certification.

Compliance

Four Readiness Checks Before Seed Moves

Industrial hemp rules vary between jurisdictions and can change. HGT uses a staged readiness check so commercial discussions do not confuse genetic potential with permission to import, possess, multiply, plant, harvest or sell a crop.

Licence & Purpose

Confirm the legal entity, authorised activity, growing location and intended use.

Variety & THC Rules

Check the relevant variety, source-crop, sampling, testing and threshold requirements for the jurisdiction.

Biosecurity & Movement

Resolve import, export, interstate movement, phytosanitary and seed-health requirements before dispatch.

Agreements & Records

Put approved use, licensing, confidentiality, traceability and reporting obligations in place before seed supply.

This framework is compliance awareness, not legal or regulatory advice. The grower, importer, exporter or licensee remains responsible for confirming current requirements with the relevant authorities.

Commercialisation

A Four-Stage Path from Opportunity to Deployment

HEMPGenTech supports commercial deployment of approved genetics through structured seed, licensing and technical collaboration pathways. No trial seed, sample seed, multiplication or commercial supply proceeds outside the required agreements and readiness checks.

Define the Opportunity

Clarify market, territory, end use, scale, proposed timing and the partner’s operating capability.

Complete Diligence

Assess technical fit, regulatory pathway, financial capacity, seed needs, multiplication plan and material risks.

Set the Agreement

Document authorised use, territory, volumes, intellectual property, confidentiality, fees, reporting and safeguards.

Deploy & Review

Coordinate supply, technical communication, traceability and agreed evaluation or commercial milestones.

  • Variety licensing
  • Regional deployment
  • Seed-company partnerships
  • Commercial production
  • Technical collaboration

Market development

Four Foundations for a Market That Can Scale

HGT’s regulatory and global-industry review work indicates that market growth depends on more than crop interest. Genetics, trusted seed pathways, production capability, processing and demand must be developed in sequence and connected by credible commercial relationships.

Demand & End Use

Start with a defined product, buyer requirement and realistic route to market.

Production Fit

Match genetics, geography, agronomy, scale and machinery with the intended product.

Processing & Logistics

Confirm harvest, storage, processing capacity, quality specifications and freight before expanding area.

Commercial Network

Connect growers, seed partners, processors, distributors, researchers and strategic capital around clear roles.

Market descriptions are not price, demand, profitability or offtake guarantees. Each opportunity requires current, project-specific validation.

News & Insights

Research, Evidence and Commercial Interpretation

HEMPGenTech publishes research summaries and technical insights that connect peer-reviewed science with practical genetics, agronomy, sustainability, policy and commercial decision-making. Readers can review the HEMPGenTech summary first, then follow the original journal or institutional link from each article.

Industrial Hemp for PFAS and Heavy-Metal Contaminated Soils

A practical summary of the 2026 peer-reviewed review by Omid Ansari and Luca De Prato, covering evidence, limitations, technology readiness and policy implications.

Read the HEMPGenTech summary

Hemp Flowering and Photoperiod

A summary of the peer-reviewed photoperiod classification work and what it means for variety selection, latitude, sowing windows and commercial fit.

Read the HEMPGenTech summary

Breeding, Environment and Flowering

Selected HGT conference insights connecting breeding objectives, genotype × environment × management and flowering behaviour.

Read the HEMPGenTech summary

More News & Insights

Explore further HEMPGenTech research summaries, industry analysis and policy-focused material as new work is released.

View all News & Insights

Commercial decision support

Information to Include in a Planting-Seed Enquiry

Providing the information below allows HEMPGenTech to determine whether HGT1, HGT2h or another pathway is appropriate to discuss. Suitability and availability are assessed case by case.

  • Country, state or region and proposed growing location
  • Intended end use: grain, fibre, dual purpose, multiplication or research
  • Expected planting area, indicative seed quantity and sowing window
  • Production system, irrigation status and harvest equipment
  • Licence, permit or compliance status relevant to the activity
  • Organisation details and person responsible for the program

Discuss an industrial hemp genetics program

Common questions

Industrial Hemp Genetics & Planting Seed FAQs

Which HEMPGenTech varieties are commercially available?

HGT1 and HGT2h are the current commercial industrial hemp varieties presented through HGT. Supply, authorised use and suitability remain subject to seed availability, location, intended purpose, regulatory requirements and an agreed commercial pathway.

Are the five 2026 PBR application varieties available?

Not by virtue of application. HOMA2hs, HARMONEY32, HASTI20, HARIR57 and HALEH98 are presented as a 2026 PBR application cohort. Application, registration, multiplication and commercial release are separate stages.

Can a variety be recommended using location alone?

No. Location must be considered alongside latitude, sowing window, intended end use, production system, management capability and suitable local evidence.

Are the 12 pipeline lines available for sale?

No. They remain under internal evaluation. Any future release depends on evidence, seed multiplication, regulatory requirements, market fit and HGT approval.

Can international organisations enquire?

Yes. International enquiries are assessed case by case, but no seed pathway proceeds until commercial agreements, permits, phytosanitary requirements, compliance checks and seed availability have been addressed.

Where can I read HEMPGenTech research and technical articles?

Peer-reviewed research summaries, technical explanations, commercial implications and policy-focused analysis are published through HEMPGenTech News & Insights. Each research summary links through to the original paper or institutional record where available.

Work with HEMPGenTech

Discuss Genetics, Research or a Commercial Opportunity

Work with HEMPGenTech on plant breeding, commercial genetics, research, seed pathways or international deployment.

Latest HEMPGenTech Insights

View all insights →